Funding Details
- Date Award
- May 13, 2024
- Vertical
- Biopharma
- Funding URL
- View Funding Page
Company Info
- Founders
- Kyle Ploense, Nathan Ogden, Damien Kudela
- Company Description
- Cayuga Biotech is a startup company developing novel hemostatic drugs and devices to treat uncontrollable bleeding episodes. Cayuga Biotech has created CAY001, a systemic drug designed to target bleeding in patients on anti-platelet drugs to reduce blood loss and save lives. CAY001’s mechanism of action potentially gives it a better safety profile than current drugs on the market, a key competitive advantage.
- Market
- Human Health
- Location
-
United States
Links